“…Su et al [25] demonstrated success rate of 97.8% in patients undergoing LBBAP with stable thresholds during a mean follow-up of 18.6 months. Particularly, LBBAP is safe and effective in patients ≥80 years old [26], and as AHREs may increase with aging [27,28], older people may benefit more from LBBAP. Additionally, HBP was associated with a significantly higher risk of complications compared with LBBAP (8.6% vs. 1.3%; P = 0.04), mainly because of more lead-related complications, whereas LBBAP was associated with a risk of complications similar to that of RVP (3.5% vs.…”